James Meyers
DirectoratArbutus Biopharma· In proxies 2023–2025
James Meyers sits on 1 public board.
Experience
- Arbutus BiopharmaPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +85%
- Sangamo TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?